Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Transcriptomics Market 2016-2020: Key Vendors are Agilent Technologies, Illumina, Roche Diagnostics & Thermo Fisher Scientific - Research and Markets

Research and Markets
Posted on: 13 Oct 16

Research and Markets has announced the addition of the "Global Transcriptomics Market 2016-2020" report to their offering.

The global transcriptomics market to grow at a CAGR of 14.10% during the period 2016-2020.

Transcriptomics involves the collection and analysis of transcriptomes of different types of cells or tissues present in an organism. The transcriptome characterizes the set of all RNA molecules, which is a part of the genetic code. The difference in genetic expression symbolizes the wide-ranging biochemical and physical differences present among various cells and tissues that may cause genetic disorders.

The report covers the present scenario and the growth prospects of the global transcriptomics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of the transcriptomics consumables, and transcriptomics instruments. The report also includes a discussion of the key vendors operating in this market.

Globally, there has been an increase in strategic initiatives among vendors in the transcriptomics market, which has significantly impacted demand in different regions. Strategic initiatives are primarily to leverage on each other's USP and that could be a strong customer base, technology, strong financial capability, or R&D capabilities to increase market share and strongly establish presence in the transcriptomics market.

For instance, in February 2014, Thermo Fisher (based in the US) acquired Life Technologies for $13.6 billion, which includes business divisions such as sera and media, chromatography instruments, purification consumables, and DNA sequencing. The combination of these two companies will provide access to advance technologies for genomics and proteomics, to accelerate life sciences research.

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Key vendors

  • Agilent Technologies
  • Illumina
  • Roche Diagnostics
  • Thermo Fisher Scientific

Other prominent vendors

  • Beckman Coulter
  • Becton
  • Dickinson and Company
  • Biological Industries
  • bioMérieux
  • Bio-Rad Laboratories
  • Cepheid
  • Clontech Laboratories
  • Cytognomix
  • Edico Genome
  • Eppendorf
  • Fluidigm
  • GE Healthcare
  • Harvard Bioscience
  • Kapa Biosystems
  • Leica Biosystems
  • Maxim Biotech
  • Molecular Devices
  • Oxford Gene Technology
  • PerkinElmer
  • Promega
  • Qiagen
  • RainDance Technologies
  • Siemens Healthcare
  • Sigma-Aldrich

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by product type

Part 07: Market segmentation by technology

Part 08: Market segmentation by PCR technology

Part 09: Geographical segmentation

Part 10: Market drivers

Part 11: Impact of drivers

Part 12: Market challenges

Part 13: Impact of drivers and challenges

Part 14: Market trends

Part 15: Vendor landscape

PART 16: Key Vendor Analysis

For more information about this report visit

View source version on

Business Wire

Last updated on: 13/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.